Podcasts about regulatory

Relational Healing, Neuroplasticity, and the Power of Psychedelic-Assisted Therapy: An Interview with Dr. Alexa Altman, Ph.D. and Shira Myrow, LMFT In this episode, Curt and Katie chat with Dr. Alexa Altman and Shira Myrow, LMFT, about psychedelic-assisted therapy and how it supports trauma healing, neuroplasticity, and relational transformation. They explore how these treatments work, what integration really means, and how therapists can ethically and safely engage with this emerging field. About our guests:Dr. Alexa Altman and Shira Myrow, MFT, are co-founders of iPsychedelic Therapy. With backgrounds in trauma-informed psychology, spiritual counseling, and relational healing, they offer a holistic approach to psychedelic-assisted therapy that centers ethical care, integration, and transformational growth. Key takeaways: Psychedelics are not shortcuts—they act as amplifiers and accelerants in trauma work. Integration is a crucial part of psychedelic-assisted therapy and often overlooked. Clinicians must examine their own biases and seek robust training. Some clients are not appropriate for these treatments due to fragility or lack of therapeutic background. A safe therapeutic container, rigorous consent, and preparation are essential. Regulatory frameworks are still emerging and need clinician involvement. More info, transcripts, and full show notes: mtsgpodcast.com Join the Modern Therapist Community: Linktree Creative Credits: Voice Over by DW McCann Music by Crystal Grooms Mangano

In this episode, the hosts analyze a Colorado gun range and retail shop listed at $2M, diving into regulatory risks, slim margins, and whether the business is worth its heavy inventory investment.Business Listing – https://www.tworld.com/agents/charleymitchell/listings/turnkey-and-established-gun-range-and-shopWelcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.

In this episode of Medsider Radio, we sat down with Howard Rosen, co-Founder and CEO of Evident Vascular, a company developing an AI-powered intravascular ultrasound (IVUS) platform to improve vascular imaging and intervention. Before co-founding Evident, Howard held senior leadership roles at Intact Vascular and Vesper Medical, guiding both companies through successful acquisitions by Philips. He also served in executive roles at Haemonetics and BG Medicine, and spent over two decades at Boston Scientific, where he held a range of leadership positions across the peripheral and cardiovascular franchises.In this interview, Howard shares why launching right — not fast — is the key to success in medtech. He breaks down how Evident built early momentum by investing in deep market validation, engaging KOLs as true collaborators, and resisting scope creep at every turn. Howard also unpacks the company's deliberate regulatory strategy, using early FDA engagement as a tool to de-risk development. On the fundraising front, he explains why board composition matters more than valuation, and why strategic acquirers respond best to credibility, not cold outreach.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Howard Rosen.

The Joint Commission's updated accreditation manual is designed to simplify requirements, enhance clarity, and better support healthcare organizations in survey preparation. In this episode of VerifiedRx, host Carolyn Liptak is joined by Dr. Robert Campbell of the Joint Commission and Diana Scott of Vizient to unpack the most significant changes. From the shift to National Performance Goals and medication safety priorities to the latest challenges in compounding, labeling, and hazardous drug handling, the conversation highlights practical insights to help pharmacy leaders stay compliant and survey-ready.   Guest speakers: Robert Campbell, PharmD, BCSCP Sr. Director, Standards Interpretation, Accreditation Decision Management,Medication Safety Division of Accreditation and Certification Operations Joint Commission   Diana Scott, MHA, RN, CPHQ Principal, Regulatory and Accreditation Services Vizient   Host:  Carolyn Liptak, , BS Pharm, MBA   Vizient   Show Notes:  [01:16-01:51] Diana and Robert Backgrounds [01:52-02:43] Changes made to the hospital and critical access hospital manuals [02:44-03:09] Changes to the chapters themselves [03:10-04:08] National Performance Goals and elaborate on those that are relevant to medication safety and pharmacy services [04:09-05:15] The top medication management challenges [05:16-06:29] Pain management not being aligned and titration orders [06:30-06:56] Insufficient communication between pharmacists, prescribers and nurses when it comes to medication orders [06:57-08:02] Themes around labeling requirements for stored medications [08:03-08:46] Anything different in removing expired meds from patient care areas and in the pharmacy this area than previous years [08:47-10:58] Issues related to storing meds specifically per the package insert [10:59-11:55] Common issues seen inside the pharmacy regarding sterile compounding, noncompliance include hand hygiene, garbing, PPE, and cleaning and disinfecting [11:56-13:12] More specifics in those area the physical environment and facility cleanliness along with cleaning and disinfection practices [13:13-14:55] Explaination of how joint Commission defines and evaluates immediate use compounding [14:56-16:09] The minimum required elements for immediate use compounding competency [16:10-17:12] Compounding competencies besides immediate use [17:13-17:54] Expectations for environmental services training [17:55- 20:14] Concerns around hazardous drugs [20:15- 21:14] Additional information   Links | Resources: Joint Commission: THE NEW STANDARD: Accreditation 360   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

Jeffrey Collins, Managing Partner of Cloverlay, stops by to discuss how Cloverlay builds private portfolios to offer clients uncorrelated returns. In this conversation, Jeff explains how Cloverlay provides access to private assets that are often overlooked by traditional investors, emphasizing the importance of correlation in portfolio management. The discussion covers various investment opportunities, including sports rights, telecom spectrum auctions, dark fiber, and intellectual property. Jeff shares insights on navigating regulatory changes and lessons learned from past investments, ultimately highlighting the future outlook for investment strategies in a rapidly evolving market.TakeawaysCloverlay specializes in esoteric niche private assets.The firm manages $1.6 billion in assets.Investments are designed to be uncorrelated and predictable.Understanding correlations is key to portfolio management.Investing in sports rights was a unique opportunity in 2020.Telecom spectrum auctions favor smaller investors.Dark fiber investments are critical for data centers.Regulatory changes can create new investment opportunities.Past investments provide valuable lessons for future strategies.Cloverlay aims to be a resource for institutional investors. Jeff's BioJeff serves as Managing Partner of Cloverlay and is a member of the Firm's Investment Committee and Board of Directors. Prior to founding Cloverlay, Jeff was a Managing Director with Morgan Stanley Alternative Investment Partners (AIP), a division of Morgan Stanley's institutional asset management business. While at AIP, Jeff was a member of the Executive and Business Committees and served on AIP's Private Markets Investment Committee as a Portfolio Manager responsible for leading primary fund, co-investment and secondary transactions focused on special situations globally and North American buyouts. Prior to AIP, Jeff advised and traded equity options and futures with U.S. hedge funds in Morgan Stanley's Equity Derivatives Group in New York. Prior to Morgan Stanley, Jeff was on the investment team at Petra Capital Partners, where he was responsible for screening, researching, structuring and monitoring private equity investments in health care and information services companies. Prior to Petra Capital, Jeff was an investment banker at Robertson Stephens, where he executed a variety of public and private equity, debt and convertible offerings along with mergers and acquisitions in financial services, health care, and business services.

The Unified Program Integrity Contractors (UPICs) are household names in healthcare compliance.But their track record tells a troubling story, according to senior healthcare analyst Frank Cohen. These Medicare fraud enforcement contractors are using controversial extrapolation techniques that providers successfully challenge over 60 percent of the time on appeal.Cohen, who will be the special guest during the next live edition of Monitor Mondays, said he will examine how the 2016 consolidation created five regional enforcement powerhouses, along with why their statistical methodologies are devastating practices based on flawed assumptions. Cohen intends to show how misaligned incentives are creating systematic accuracy problems, while revealing why the current UPIC system might be fundamentally broken, despite everyone agreeing that fraud prevention matters.The weekly broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Matthew Albright, chief legislative affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.

At the EUVC Summit 2025, Kerry Baldwin (IQ Capital) and Chris Elphick led one of the most urgent conversations of the year:Can Europe mobilize its pension capital to fund innovation—or will it stay stuck on the sidelines?With £1 trillion expected to be funneled into innovation, growth, and venture by 2030, the opportunity is massive. But unlocking it will take more than speeches and slogans. It will take structures, translation, and a whole lot of education.Chris opened by setting the context:In July 2023, 10 of the UK's largest pension funds agreed to invest 5% of assets into unlisted equities—representing £5 billion of fresh capital.That capital is (unsurprisingly) biased toward private equity. But the real win?Getting a meaningful slice of it into venture.We now have the technical tools to do it:The introduction of Long-Term Asset Funds (LTAFs)—with 27 launched to date—means the legal infrastructure is in place.Regulatory shifts have opened the door. Now it's time to walk through it.“The pipes are built. Now we need to make the case.”As Kerry pointed out, it's not just about access—it's about alignment.“The pension world doesn't speak venture. It speaks in valuations, risk ratings, board approvals, and actuarial models.”To bridge the gap:Ditch the pitch decks. Instead, build relationships.Use case studies. Show, don't just tell.Speak their language. Get founders in the room. Educate through stories and real-world examples.And yes, explain your fees—transparently.→ “We charge fees because we hunt. We engage with professors. We run deep knowledge sessions. That's where the value lives.”Kerry closed with a critical reminder from someone who's seen the cycles before—2001, 2009, and now:“Just play nicely.”→ That means fair terms.→ Respecting early-stage angels.→ Not forcing founder-unfriendly clauses when capital is tight.Venture doesn't work when trust is broken at the seed layer.The prize is on the table. The pipes are laid. The policymakers are listening.Now it's up to us—as GPs, founders, LPs, and ecosystem builders—to:Make venture legibleBuild long-term trustAnd design financial vehicles that serve founders, fuel returns, and unlock national innovation agendas“Let's stop waiting for the future to finance itself. Let's build the financial architecture to fund it now.”The Landscape: Shifting Regulations, Real PotentialThe Real Bottleneck? Language & UnderstandingA Word of Warning: Don't Harm the EcosystemA Trillion-Pound Opportunity—If We Get This Right

Hosts Karl Schmieder and Erum Azeez sit down with Dr. Kyle Landry, President and Co-founder of Delavie Sciences, to explore how extremophiles—microbes that survive in the harshest environments on Earth and space—are unlocking new frontiers in skincare and longevity. Kyle shares his unconventional path from food science to biodefense to NASA collaborations, revealing how a microbe that survived 18 months outside the International Space Station became the foundation for a groundbreaking sunscreen ingredient. The conversation dives into longevity science, microbial resilience, the future of skincare as true preventative health, and the entrepreneurial challenge of scaling biotech innovations from test tube to industrial reactors.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Links and Resources:Chris Mason Episode Kate Rubins Episode Erika DeBenedictis EpisodeLifespan.ioFight Aging! Delavie Sciences David Sinclair's Novel - Lifespan: Why We Age and Why We Don't Have To Efficacy of a Novel SPF Booster Based on Research Aboard the International Space StationNASA iTECHChapters:(00:00:00) - Introduction to the episode and the Grow Everything podcast(00:00:49) - Aging by Biotech NYC event overview(00:03:35) - Tips on being a great moderator(00:04:03) - Keys to moderating well: preparation and audience engagement(00:07:20) - Notable absence of space topics at longevity event(00:09:40) - Guest introduction: Dr. Kyle Landry and his background(00:10:13) - Story of how the hosts met Kyle Landry(00:11:42) - Career journey from food science to skincare(00:14:27) - Inspiration from space research leading to Delavie Sciences(00:17:25) - How Delavie's product works at a molecular level for sun protection and anti-aging(00:20:43) - Evolution of the space microbe and cultivation on Earth(00:22:31) - What it means for a microbe to “sit outside the space station”(00:23:26) - Professional connections with other Grow Everything guests, Chris Mason and Dr. Kate Rubins(00:24:29) - Potential for Delavie to expand beyond skincare into new industries(00:26:11) - Lessons from researching extremophiles and challenges of working with new organisms(00:28:22) - Role in mentoring students and researchers(00:31:36) - Rethinking health and resilience in biotechnology(00:33:20) - Exploring the “product versus platform” dilemma in biotech entrepreneurship(00:34:48) - How Delavie functions as both a technology platform and a product company(00:36:29) - Corporate partnerships and product applications of Delavie's ingredients(00:38:53) - Clarification: using microbial compounds, not live bacteria, in products(00:39:59) - Importance of protecting the skin microbiome without disrupting it(00:42:46) - The future of skincare and longevity(00:45:03) - Quick-fire questions begin(00:45:19) - Weirdest place to hunt for a microbe(00:45:31) - Bio-fact most people don't believe but should(00:46:48) - Personal skincare non-negotiable(00:48:20) - Would you rather halt or reverse aging?(00:48:51) - Weirdest place a sample has been collected(00:51:14) - Post-interview reflections and discussion(00:52:54) - Takeaways from the interview and the concept of convergence(00:54:03) - Conversation on Umami flavor and UV light spectrums(00:56:00) - Regulatory differences in sunscreen between the US and Europe(00:58:14) - Announcement of the BioFabricate Fair and listener discount codeTopics Covered: biotech beauty, space biotech, skin care, biomanufacturing, longevity, extremophiles  Have a question or comment? Message us here:Text or Call (804) 505-5553Instagram  / Twitter / LinkedIn / Youtube / Grow Everything

Kate Taylor, Associate Principal, ECG Management Consultants, speaks with Katie Tarr, Shareholder, LBMC, Alaina Crislip, Member, Jackson Kelly PLLC, and Payal Shah, Senior Counsel, Vituity, about some of the financial and regulatory pressures (and resulting compliance breakdowns) they are seeing in the health care industry and strategies and solutions for navigating the intersection of financial constraint and regulatory compliance. They offer insights from the in-house counsel, external counsel, and consultant perspectives. From AHLA's Women's Leadership Council.Watch this episode: https://www.youtube.com/watch?v=qoc8699BvsAEssential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Jeremiah Mosteller, attorney and policy director at Americans for Prosperity, joins the conversation to explain why Congress should follow up tax reform with meaningful regulatory relief. He points to the success of the One Big Beautiful Bill Act's tax reforms as a strong first step, but stresses that real, lasting prosperity requires reducing the regulatory burdens that stifle innovation, business growth, and opportunity for everyday Americans.

AI isn't just a support tool anymore—it's becoming the strategist.As the next generation of autonomous AI agents begins to emerge, we're seeing a shift from task-based assistance to full-cycle execution. These agents don't just draft content or summarize research—they can now run processes from start to finish with minimal human involvement. From preparing client reports to organizing internal communications, these tools have the potential to fundamentally reshape the way wealth management firms operate. For smaller firms, they could even become the competitive equalizer.But this isn't about plugging AI into outdated workflows. It's about letting AI pursue outcomes—more efficiently, more creatively, and sometimes in ways humans wouldn't have thought to design. I explore how firms can start experimenting with agents in low-risk areas, build internal comfort and skill, and evolve toward deeper integration. I also dive into what it looks like to shift your team's mindset: from managing step-by-step processes to defining clear end goals and trusting AI to find the path.Regulatory frameworks are evolving just as fast. With new initiatives like AI sandboxes and emerging tax incentives for workforce training, firms have a chance to shape—not just follow—the rules. I walk through how to align your governance with existing standards, and why compliance shouldn't be an afterthought. If we want AI to be a long-term partner, we need to set it up with the same intention and clarity we'd expect from any team member. This is about building a future where results—not routine—define success.

In this episode of Medsider Radio, we sat down withTracy MacNeal, President and CEO of Materna Medical. Materna is developing two devices addressing different aspects of pelvic health: Ellora, aimed at preventing childbirth injuries during delivery, and Milli, designed to treat vaginismus, a pelvic floor condition that makes intercourse painful or impossible.Tracy is a healthcare executive and engineer with over 25 years of experience in medical devices, digital health, and women's health, including six successful transactions. In addition to heading Materna, Tracy serves on the AdvaMed Board and leads its Women's Health Equity Initiative, and was previously President of Diagnostics and Digital Health at Ximedica.In this interview, Tracy shares how clinical data enabled Materna to bridge B2B and B2C channels, and why clarity of focus is essential when commercialization paths diverge. Tracy also outlines what it takes to build in undefined markets, from aligning KOLs to publishing foundational definitions, and offers a candid perspective on what investors really want: clear financial returns, backed by a founder they trust to deliver when things go sideways.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Tracy MacNeal.

Leah Wald joins Sam Vadas as cryptocurrencies and crypto-related equities plummet in Tuesday's trading. She saw a “classic supply squeeze pattern” in Bitcoin as it ran to highs. She also examines the surging popularity of Ethereum (/ETH) and thinks money is rotating out of “pure speculative plays” in smaller coins into more established tokens. Leah thinks people are getting excited about blockchains with interest from institutional players, driving major inflows – with DC, and 401(k)s as the next step in the “regulatory revolution.” She concludes, “I couldn't feel more bullish.”======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

An effective compliance program, as outlined in the U.S. Sentencing Guidelines, incorporates seven key elements to prevent and detect organizational misconduct. First, organizations must establish clear standards and procedures to ensure legal and ethical conduct, supported by comprehensive training and communication to promote awareness. Second, high-level personnel must oversee the program, ensuring accountability, while specific individuals are responsible for its implementation. Finally, regular monitoring, auditing, a system for confidentially reporting violations, consistent enforcement, and periodic risk assessments ensure the program's ongoing effectiveness. Two CITI Program colleagues, Andra M. Popa, JD, LLM, Assistant Director of Healthcare Compliance, and Anne Hawkins-Badge, DHSc, MSPH, Assistant Director of Environmental Health and Safety, discuss their respective regulatory expertise that directly aligns with the U.S. Sentencing Guidelines' seven key elements. In their discussion, they highlight the similarities and skills that may apply to a professional compliance position from their respective backgrounds.  Additional Resources: CITI Program's Healthcare Solution:                https://about.citiprogram.org/solutions/healthcare/ CITI Program's Health and Safety Solution: https://about.citiprogram.org/solutions/health-safety/ CITI Program's Higher Education Training Solution: https://about.citiprogram.org/solutions/higher-education/  

Welcome to Automating Quality, the life sciences–focused show that bridges the gap between automation and quality management. In today's episode, our host Philippe welcomes Jim Ferguson, President and Owner of NuQual Consulting. With over 25 years of experience in the life sciences industry, Jim brings deep expertise in supplier quality and compliance. Together, they dive into the world of internal audits — how they can be used not only to maintain compliance but also to proactively identify and resolve potential observations before a regulatory inspection takes place.   Key Takeaways 01:22 Introducing today's guest, Jim Ferguson from NuQual Consulting 02:18 What quality-focused events has Jim been attending lately? 04:30 How can internal audits help organizations prepare for regulatory inspections or other types of audits? 07:25 What is the value of outsourcing internal audits? 08:35 How can companies ensure that audit findings actually lead to meaningful changes? 12:57 What does a strong response to internal audit findings look like? 17:30 What are some common pitfalls organizations tend to overlook during internal audits?   Contact Jim at https://nuqualconsulting.ca/ Contact us at solabs-podcast@solabs.com

In this exclusive episode of Paisa Vaisa, we host Sanjay Dutt, MD & CEO of Tata Realty & Infrastructure Ltd. A true industry veteran, Dutt unpacks the dramatic evolution of the Indian real estate sector. He traces the market's growth from the pre-liberalization era of the 80s, where office space was a mere 20-30 lakh sq ft, to today's staggering 750 million sq ft of Grade-A space. The conversation covers key trends driving the market today, including the phenomenal growth of various sub-sectors like data centers, senior living, student housing, and industrial warehousing. Sanjay Dutt also shares his expert opinion on the future trajectory of the sector, the influx of global capital, and the crucial impact of regulatory reforms like RERA and the Insolvency and Bankruptcy Code. Pointers: ✔ Historical context: A look back at real estate before liberalization and its explosive growth since the 90s. ✔ Market segmentation: The expansion of the industry into diverse segments like co-living, data centers, and senior living. ✔ Geographic growth: Insights into how tier-1 cities are creating their own "tier-2" sub-markets and the potential for a more balanced growth across India. ✔ Investment vs. speculation: The difference between wealth creation and trading, and where to spot a potential bubble. ✔ Navigating the market: A detailed guide on what to look for when buying property, from freehold titles to developer reputation. ✔ Regulatory impact: The positive, life-changing influence of RERA and insolvency codes on transparency and investor confidence.From decoding your personal finances to demystifying business models, Paisa Vaisa delivers candid, insightful, and jargon-free conversations. Listen on Spotify, Apple Podcasts, Amazon Music, JioSaavn, Gaana & more Watch full episodes right here on YouTube Explore more at ivmpodcasts.comConnect with Anupam Gupta: Twitter: @b50 Instagram: @b_50 LinkedIn: Anupam Gupta Follow IVM Podcasts We’re @ivmpodcasts on Facebook, Twitter & InstagramSee omnystudio.com/listener for privacy information.

Compounded medications serve a critical role in meeting patient-specific needs, but compliance is essential to ensure safety and quality. This episode covers what pharmacists need to know about documentation, prescription validity, beyond-use dating, and common missteps that can put compliance at risk. Tune in to strengthen your compounding practices and stay aligned with current regulatory expectations.  HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactJessica Gustin, PharmDCMO & PIC/COOGwinnett Drugs/SynerGrxJoshua Davis Kinsey and Jessica Gustin have no relevant financial relationships to disclose. Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify key compliance requirements related to patient-specific prescriptions and compounded medication preparation. 2. Describe common compliance challenges in pharmacy compounding and strategies to avoid regulatory missteps. 0.05 CEU/0.5 HrUAN:  0107-0000-25-273-H07-P Initial release date: 8/18/2025Expiration date: 8/18/2026Additional CPE details can be found here.

There just might be a reign of terror being experienced at many of America's hospitals and health systems. Professionally delivered patient care apparently seems to be getting hijacked by auditors compelled to deny claims of omission.Aided by the Centers for Medicare & Medicaid Services (CMS) and abated by auditors private and public, the lingua franca appears be an entanglement of descriptors, namely “inpatient versus outpatient.”During the next live edition of the venerated Monitor Monday broadcast, several of the most recognized names in healthcare will not add to the confusion, but offer advice for those on the front lines of battle.The weekly broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Cate Brantley, senior healthcare government affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.

Compounded medications serve a critical role in meeting patient-specific needs, but compliance is essential to ensure safety and quality. This episode covers what pharmacists need to know about documentation, prescription validity, beyond-use dating, and common missteps that can put compliance at risk. Tune in to strengthen your compounding practices and stay aligned with current regulatory expectations. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactJessica Gustin, PharmDCMO & PIC/COOGwinnett Drugs/SynerGrxJoshua Davis Kinsey and Jessica Gustin have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify key compliance requirements related to patient-specific prescriptions and compounded medication preparation. 2. Describe common compliance challenges in pharmacy compounding and strategies to avoid regulatory missteps. 0.05 CEU/0.5 HrUAN:  0107-0000-25-273-H07-P Initial release date: August 18, 2025Expiration date: August 18, 2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Summary Nel nuovo episodio del nostro podcast, parliamo di un tema spesso percepito come tecnico e complesso, ma in realtà sempre più strategico: il mondo del Regulatory nei rivestimenti industriali. Ne discutiamo con Alice Paiotta, Regulatory & Quality Assurance Manager Europe in Carboline, che ci guida in un viaggio tra REACH, sostenibilità, rischi normativi, competitività e innovazione. Timestamps 00:53 – Introduzione 01:16 – Presentazione dell'ospite: Alice Paiotta 02:03 – Che cos'è il regulatory in un'azienda che produce rivestimenti e prodotti antincendio 02:40 – I principali regolamenti applicabili in Europa 03:34 – Focus sul Regolamento REACH 04:21 – Le autorità competenti in Europa per il settore dei rivestimenti 05:44 – Come è evoluta la regolamentazione negli ultimi decenni 08:22 – Codice UFI: di cosa si tratta e a cosa serve 08:53 – Il futuro del regulatory secondo Alice 10:46 – L'aggiornamento delle liste di sostanze: un processo continuo 11:14 – Regolamenti europei e sostenibilità: sempre più interconnessi 13:33 – Le conseguenze della non conformità normativa (legali, economiche, reputazionali) 16:20 – Come assicurarci di non commercializzare prodotti non conformi 19:25 – Regulatory come vantaggio competitivo: quando la conformità diventa strategia 22:50 – Le principali sfide da affrontare per restare conformi 24:48 – Il percorso di Alice: dalla chimica al regulatory 28:02 – Domande extra per chiudere in leggerezza

On this episode Lara and Vyanka talk to Prof Adrian Liston from the University of Cambridge all about regulatory T cells and the role they play in the periphery and in treating neuroinflammatory disease. This is ImmunoTea: Your Immunology Podcast, presented by Dr Lara Dungan and Dr Vyanka Redenbaugh. This is the show where we tell you all about the most exciting research going on in the world of immunology. So grab a cup of tea, sit down and relax and we'll fill you in. Contact us at ImmunoTeaPodcast@gmail.com or @ImmunoTea on twitter. Hosted on Acast. See acast.com/privacy for more information.

Our friend, physicist and economist Erald Kolasi, stops by the Macro N Cheese clubhouse to talk with Steve about the profound effects of AI on the energy grid, water resources, and societal infrastructure. The discussion focuses primarily on large-scale corporate AI, such as generative AI. Erald's work bridges physics, economics, and ecology, revealing how AI's rapid expansion is not just a technological phenomenon but a biophysical crisis – one that's easy to overlook. Cloud is such a gentle word. Diaphanous. It sounds harmless. Lovely, even.“When you're in front of your computer and you're just typing away and you're asking these systems to do all these magical things for you, it can seem like it comes out of nowhere. But no, in reality, all of this stuff takes enormous energy.” AI's dematerialized facade obscures its physical infrastructure. It's a classic capitalist contradiction where "progress" accelerates ecological breakdown. Erald and Steve talk about the race to the bottom, as states and municipalities trade public health for tax revenue. Regulatory enforcement is absent. While exploiting labor and plundering nature, the costs are socialized as these companies use public water and energy grids. Elon Musk's xAI Colossus is based in Tennessee. (Remember the TVA, that impressive example of depression-era federal works? Help yourself, Elon.) It's not just that they use public water and energy, it's the vast and growing amounts of these resources, as Erald explains. The conversation also touches on the AI arms race, as the US competes with China, using “national security” as an excuse to justify resource wars. From energy consumption to water depletion, from labor displacement to geopolitical tensions, this episode exposes the contradictions of AI under a system that prioritizes profit over sustainability. Erald Kolasi is a writer and researcher focusing on the nexus between energy, technology, economics, complex systems, and ecological dynamics. His book, The Physics of Capitalism, came out from Monthly Review Press in February 2025. He received his PhD in Physics from George Mason University in 2016. You can find out more about Erald and his work at his website, www.eraldkolasi.com. Subscribe to his Substack: https://substack.com/@technodynamics

Text us a pool question!This week on Floc-It Friday, Rudy sits down with Greg “Beard Man” Beard—poolside philosopher, calcium whisperer, and one of the Top 10 Mentors nominated for the 2025 Talking Pools Podcast Mentor of the Year Award. Greg has spent 35 summers in the field training rookies, guiding veterans, and mentoring like it's a martial art.From confronting internet undercutting to saving techs from costly mistakes, Greg shares the lessons, stories, and no-BS truths that define a lifetime in the pool industry. And yes, Rudy announces the full list of Top 10 Mentor of the Year finalists, with shout-outs to the sponsors making it possible.In This Episode:

BioLongevity Labs is a health optimization company that focuses on peptides, bioregulators and small molecules. While much of the biohacking community knows about these compounds, general awareness is low, with only 3% of Americans familiar with therapeutic peptides, according to BioLongevity Labs Cofounder Hunter Williams.

Send us a textAI in Pathology: ML-Ops and the Future of DiagnosticsWhat if the most advanced AI models we're building today are doomed to die in the machine learning graveyard?

In an era where organizations depend heavily on commercial applications to run their operations, the integrity of those applications has become a top security concern. Saša Zdjelar, Chief Trust Officer at ReversingLabs and Operating Partner at Crosspoint Capital, shares how protecting the software supply chain now extends far beyond open source risk.Zdjelar outlines how modern applications are built from a mix of first-party, contracted, open source, and proprietary third-party components. By the time software reaches production, its lineage spans geographies, development teams, and sometimes even AI-generated code. Incidents like SolarWinds, Kaseya, and CircleCI demonstrate that trusted vendors are no longer immune to compromise, and commercial software can introduce critical vulnerabilities or malicious payloads deep into enterprise systems.Regulatory drivers are increasing scrutiny. Executive Order 14028, Europe's Cyber Resilience Act, DORA, and U.S. Department of Defense software sourcing restrictions all require greater transparency, such as a Software Bill of Materials (SBOM). However, Zdjelar cautions that SBOMs—while valuable—are like ingredient lists without recipes: they don't reveal if a product is secure, just what's in it.ReversingLabs addresses this gap with a no-compromise analysis engine capable of deconstructing any file, of any size or complexity, to assess its safety. This capability enables organizations to make risk-based decisions, continuously monitor for unexpected changes between software versions, and operationalize controls at points such as procurement, SCCM deployments, or file transfers into critical environments.For CISOs, this represents a true technical control where previously only contractual clauses, questionnaires, or insurance policies existed. By placing analysis at the front of the software lifecycle, organizations can reduce reliance on costly manual testing and sandboxing, improve detection of tampering or hidden behavior, and even influence cyber insurance rates.The takeaway is clear: software supply chain security is a board-level concern, and the focus must expand beyond open source. With the right controls, organizations can avoid becoming the next headline-making breach and maintain trust with customers, partners, and regulators.Learn more about ReversingLabs: https://itspm.ag/reversinglabs-v57bNote: This story contains promotional content. Learn more.Guest: Saša Zdjelar, Chief Trust Officer at ReversingLabs and Operating Partner at Crosspoint Capital | On Linkedin: https://www.linkedin.com/in/sasazdjelar/ResourcesLearn more and catch more stories from ReversingLabs: https://www.itspmagazine.com/directory/reversinglabsLearn more about ITSPmagazine Brand Story Podcasts: https://www.itspmagazine.com/purchase-programsNewsletter Archive: https://www.linkedin.com/newsletters/tune-into-the-latest-podcasts-7109347022809309184/Business Newsletter Signup: https://www.itspmagazine.com/itspmagazine-business-updates-sign-upAre you interested in telling your story?https://www.itspmagazine.com/telling-your-storyKeywords: Black Hat 2025, Black Hat USA, sean martin, saša zdjelar, software supply chain security, commercial software risk, binary analysis, software bill of materials, sbom security, malicious code detection, ciso strategies, third party software risk, software tampering detection, malware analysis tools, devsecops security, application security testing, cybersecurity compliance

Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe's most active longevity-focused venture capital firms, currently raising its second fund targeting $250 million.In this episode, Chris and Sergey explore the investment landscape shaping longevity biotechnology today. They discuss LongeVC's pragmatic approach to longevity investing—focusing on disease-modifying therapies rather than targeting aging itself—and why this strategy has been successful across their portfolio. Sergey shares insights from major successes including Rubedo's $500M+ partnership with Bristol Myers Squibb and Turn Bio's $300M deal with Hansol, explaining what these deals signal about pharma's evolving interest in longevity approaches. The conversation covers critical topics for researchers and entrepreneurs: common pitfalls in academic spin-offs, the importance of clear regulatory pathways, and how the upcoming patent cliff is creating new opportunities for early-stage biotechs in the longevity space.Listeners will gain valuable insights into what makes a longevity company investable, how to navigate the transition from academic research to commercial venture, and why solving age-related diseases one by one may ultimately lead to a holistic understanding of aging itself.The Finer Details:Sergey's journey from aspiring neurosurgeon to deep tech entrepreneur to longevity investorLongeVC's pragmatic philosophy: targeting specific diseases rather than aging as a wholeThe convergence of biotech, regenerative medicine, and AI in the longevity spaceKey criteria for early-stage investment: disease indication, balanced teams, clean IP transferWhy "five scientists in a room" and "great mouse data" don't make an investable companyThe importance of platforms having their own pipelines, not just service modelsHow LongeVC's scientific advisory board (including Alex Zhavoronkov, Vadim Gladyshev, Thomas Rando) evaluates investmentsSuccess stories: Rubedo's senolytic partnership and Turn Bio's epigenetic reprogramming dealThe changing dynamics between pharma and biotech driven by patent cliffs and urgency to find the "next GLP-1"Regulatory strategies: focusing on specific endpoints rather than aging broadlyMaking longevity medicine accessible through disease-focused approaches and data-driven validationPersonal motivation: Sergey's experience as a rare disease patient and the urgency of advancing treatmentsQuotes:"Longevity as an industry is by far the industry with the biggest added value out there, because that is the issue that we all share. Without solving these things, none of the other stuff really matters—not FinTech, not blockchain, not sustainability.""Five scientists in a room generally don't make a company. Prolonging rodent lives does not make a company either.""The ultimate longevity drug version 1.0 would be a therapeutic which has an original disease indication, which also has somehow cracked the mechanism of action that would be translatable across several age-related disease domains.""It is extremely arrogant for the space to say that we're not interested in age-related diseases, like we're not interested in curing the diseases. That's traditional biotech. We're not that. We are the longevity space.""Pharma is still thinking in terms of assets rather than processes. It is almost impossible to sell a process to them... What pharma still wants is the result of that capacity actually coming to life.""At the point when something has happened to you and a rare disease has happened to you... you're only equipped with that standard of treatment that is currently available and that has made it to the clinic.""I think the presence of the FDA as this kind of gatekeeper-type agency saying, 'No, you...

In this Technology Reseller News and Cloud Communications Alliance preview of the upcoming CCA Financial Summit (October 7, 2025, Willard Hotel, Washington, D.C.), Doug Green speaks with Michael Quinn, Founding Partner at Q Advisors, and Jonathan Marashlian, Managing Partner at The CommLaw Group. The session they will lead—aptly titled Hotel California and the Regulatory Impact on Cloud Transactions—explores how certain state-level telecom regulations, especially in California, are causing costly delays and uncertainty in cloud and VoIP M&A activity. Quinn explains the analogy: “You can check in, but you can never leave. That's how it feels when a deal gets stuck in California's opaque approval process.” He notes that even transactions with minimal in-state revenue can be held for months, slowing an industry that's rapidly evolving with AI and new technologies. Marashlian details the legal backdrop, pointing to the erosion of the Vonage preemption and the California Public Utilities Commission's expanded reach into VoIP. “For 20 years, states generally took a hands-off approach to VoIP market entry and transactions. Now, with California leading the way, we're seeing a spider web of regulatory requirements emerging,” he warns. The result: unpredictable timelines, heightened legal exposure, and the risk that other states will follow suit. Both agree that while consumer protection is vital in traditional telecom, these rules are misapplied to business-focused VoIP and UCaaS providers, where customers are sophisticated and competition is abundant. They urge federal action—specifically FCC reaffirmation of Vonage preemption—to restore clarity, prevent regulatory overreach, and allow businesses to plan transactions with certainty. More information on the speakers and their work is available at commlawgroup.com and qllc.com. Learn more about the CCA Financial Summit and register at https://www.cloudcommunications.com/events/financial-summit-2025.

We'd love to have your feedback and ideas for future episodes of Retail Unwrapped. Just text us!While consumers fixate on tariffs as the primary force behind rising food prices, the reality is far more complex and revealing. Regulatory changes, labor costs and operational expenses coupled with new tariff pressures on some food categories are creating uncharted supply-demand dynamics. Join Shelley and Stew Leonard, Jr., president and CEO of Stew Leonard's as they discuss the three-tier cost structure that's creating permanent price pressures and reveal surprising consumer behaviors that smart retailers are leveraging for a competitive advantage.Special Guest: Stew Leonard Jr., President & CEO, Stew Leonard's For more strategic insights and compelling content, visit TheRobinReport.com, where you can read, watch, and listen to content from Robin Lewis and other retail industry experts, and be sure to follow us on LinkedIn and Twitter.

Jeffrey Pritchard, Legal Director of the Coalition for Political Forecasting, analyzes lawsuits about Kalshi's sports contracts and their implications for prediction markets. Rule3O3 discusses Indian-American gender divides and the impact of childhood grievances on politics. Timestamps 0:11: Chougule introduces segment with Pritchard 1:07: Chougule introduces Rule3O3 segment 1:28: Mamdani victory 2:10: Intro ends 4:10: Pritchard segment begins 4:13: Why Kalshi wants to be regulated under federal law 4:41: State regulation 6:34: CFTC 7:24: State compliance costs 7:43: Kalshi's goal 9:09: Liquidity 10:59: Criticisms of Kalshi 11:08: Zubkoff tweet 12:40: Pritchard agreement with Zubkoff 12:54: Contradictions in Kalshi's position 13:41 : Mansour response to Zubkoff 14:37: Pritchard response to Mansour 16:28: Chougule's view of Kalshi sports contracts 18:28: Chougule defends Kalshi 19:46: Market demand for sports betting 20:24: The need to attract sports bettors  21:22: Regulatory environment 22:53: Retail traders 24:01: Gaming industry 29:48: Lawsuits 29:58: Nevada 30:37: New Jersey 31:15: Maryland 31:23: Illinois 31:46: Third Circuit 32:11: Timing 32:24 : Pritchard segment ends 32:39: Rule 3O3 segment begins 32:41: Gender divides among Indian-Americans 32:54: Saira Rao 33:22: White women 35:51: Finding an edge through elite thinking 36:06: Childhood trauma 36:57: Outsider psychology 37:34: Political biographies 38:20: UVA rape accusation 40:31: Crime demographics in mainstream media 42:41: Rule3O3 segment ends 42:57: DC August Forecasting and Prediction Markets meetup Star Spangled Gamblers is a podcast on betting and winning real money on politics. SUPPORT US: Patreon: www.patreon.com/starspangledgamblers FOLLOW US ON TWITTER/X: @ssgamblers VISIT OUR WEBPAGE: www.starspangledgamblers.com  Trade at Polymarket.com, the world's largest prediction market. Join us for our monthly DC Forecasting & Prediction Markets meetup on Thursday, August 14 from 6-9pm. We're returning to Rocklands BBQ in Arlington a few blocks from the Virginia Sq-GMU metrorail stop on the Orange/Silver line. Free parking also available. We'll be in the private space upstairs; head to the back of the restaurant, and up the stairs on your left. Our guest speaker this month is Ambassador Tom Miller. A 29-year career diplomat, Ambassador Miller's experience in the Foreign Service spanned many continents, including posts in Greece, Bosnia-Herzegovina, Cyprus, Thailand as well as the State Department in Washington, where he worked on North Africa, the Middle East, and counter-terrorism issues. From 2019 to 2022, Tom was Chair of the Board of the US subsidiary of Intralot, Inc., a US corporation that runs lotteries in 11 states. Last-minute/onsite walk-in RSVPs here on this Partiful event page are welcomed! https://partiful.com/e/2VIW9cQaw6pexbaQSmUh?f=1&photo=all Who are we? We are prediction market traders on prediction markets like Kalshi, Manifold, PredictIt, and Polymarket, forecasters (e.g. on Metaculus and Good Judgment Open), sports bettors (e.g. on FanDuel, DraftKings, and other sportsbooks), consumers of forecasting (or related) content (e.g. Star Spangled Gamblers, Nate Silver's Silver Bulletin, Scott Alexander's Astral Codex Ten), effective altruists, rationalists, futurists, and data scientists. Forecast on Manifold how many people will attend meetups this year: https://manifold.markets/dglid/how-many-attendees-will-there-be-at?play=true This meetup is hosted by the Forecasting Meetup Network. Help us grow the forecasting community to positively influence the future by supporting us with an upvote, comment, or pledge on Manifund: https://manifund.org/projects/forecasting-meetup-network---washington-dc-pilot-4-meetups Get notified whenever a new meetup is scheduled and learn more about the Forecasting Meetup Network here: https://bit.ly/forecastingmeetupnetwork Join our Discord to connect with others in the community between monthly meetups: https://discord.com/invite/hFn3yukSwv

Julie Lein, Managing Partner at Urban Innovation Fund, shares what it takes to get funded in today's market. From mastering your pitch to leveraging AI and regulatory tailwinds, Julie breaks down how to stand out to investors. We also dive into her cold email formula, first meeting strategy, and what makes a founder unforgettable. Top Moments 05:31 Why it's never too early to pitch and how progress between meetings wins investors. 11:42 Julie explains Urban Innovation Fund's AI-native and AI-accelerated investment approach. 16:58 Regulatory tailwinds: the underrated driver of billion-dollar opportunities. 24:17 Why evangelism and storytelling are now non-negotiable for founders. 33:09 Julie's cold email formula that gets founders meetings (and checks). 38:45 Inside the first investor meeting: product demos, partner discussions, and market vision.

Banking executives face a familiar dilemma: decades-old core systems technically constrain innovation while replacement costs can reach hundreds of millions of dollars and take years to implement. Meanwhile, fintechs launch new products in weeks while traditional banks remain trapped in months-long approval cycles. The challenge extends beyond technology. "Most banks duct-tape capabilities onto what they already have, and eventually they break," explains Ritesh Rihani, Vice President of Enterprise Banking at Galileo. "You've seen the number of outages we've had in the industry recently. That's all happening because they put duct tape upon duct tape." The pressure to modernize comes from multiple directions. Customer expectations have evolved toward integrated experiences and ease of use and operational risks multiply as the pool of COBOL programmers shrinks through retirement. Regulatory compliance becomes increasingly difficult with manual processes and fragmented systems. This podcast explores five critical dimensions of core modernization: balancing costs with competitive necessity, understanding operational and regulatory risks, implementing incremental transformation strategies, enabling product innovation, and unlocking the future potential of modern banking architecture.

Send us a textExplore how family offices and investors are navigating the digital asset space — from Bitcoin and blockchain to NFTs and tokenized real-world assets. This panel brings together experienced crypto entrepreneurs, investors, and advisors who discuss:- Why smart capital is finally allocating to crypto- Bitcoin vs altcoins: where to start- Regulatory shifts and global adoption- Web3 infrastructure and investment opportunitiesWhat skeptics are missing in 2025- Real-world crypto use cases beyond speculationWhether you're new to digital assets or looking to refine your strategy, this discussion offers grounded insights and practical advice from professionals with skin in the game.

Tshidi Madia in for Clement Manyathela speaks to Willie Aucamp, the DA National Spokesperson about the party’s proposed alternatives to Broad-Based Black Economic Empowerment, the Employment Equity Act and the Expropriation Act, calling these a hindrance to economic growth. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Get your FREE Cybersecurity Salary Guide: https://www.infosecinstitute.com/form/cybersecurity-salary-guide-podcast/?utm_source=youtube&utm_medium=podcast&utm_campaign=podcastDavid Close, Chief Solutions Architect at Futurex, discusses the reality facing our digital world: quantum computing will soon break the encryption protecting everything from mobile banking to satellite communications. But here's the twist — hackers aren't waiting. They're harvesting encrypted data now, betting that quantum computers will eventually crack today's "unbreakable" codes in a strategy called "harvest now, decrypt later." David explains how NIST's new post-quantum cryptography standards are already being deployed by companies like Google and CloudFlare, why crypto agility is essential for future-proofing your security infrastructure, and how you can break into the exciting field of cryptography — even without a PhD in mathematics.0:00 - Intro 1:00 - Cybersecurity Salary Guide3:06 - Meet David Close from Futurex3:52 - David's journey from embedded systems to cryptography5:05 - What Futurex does and 40 years of crypto innovation6:39 - The role of Chief Solutions Architect8:21 - Evolution of cryptography from payments to enterprise10:13 - How David discovered his passion for cryptography13:23 - Post-quantum cryptography explained15:16 - Why quantum computers break current encryption16:05 - The "harvest now, decrypt later" threat18:19 - NIST's new quantum-resistant algorithms20:02 - Real-world quantum threats to satellites and IP22:43 - What organizations can do now25:25 - Crypto agility and future-proofing systems28:41 - Resources for staying current on cryptography30:45 - Career paths in cryptography beyond algorithm development32:18 - Getting started in cryptography careers34:26 - The cryptography landscape in 15 years37:34 - Regulatory enforcement of new crypto standards39:43 - Best career advice: Finding the right vehicle41:29 - David's current reading and recommendations42:35 - Where to find David and Futurex onlineView Cyber Work Podcast transcripts and additional episodes: https://www.infosecinstitute.com/podcast/?utm_source=youtube&utm_medium=podcast&utm_campaign=podcastAbout InfosecInfosec's mission is to put people at the center of cybersecurity. We help IT and security professionals advance their careers with skills development and certifications while empowering all employees with security awareness and phishing training to stay cyber-safe at work and home. More than 70% of the Fortune 500 have relied on Infosec to develop their security talent, and more than 5 million learners worldwide are more cyber-resilient from Infosec IQ's security awareness training. Learn more at infosecinstitute.com.

Jon kicks off the show talking about the continued Canadian wild fires, Trump meeting with Putin, the latest regulatory issues that matter to you and more with DC Correspondent Andrew Langer 

Although the lawsuit was filed by a pharmacist in New Mexico, a federal judge in New York has ordered CVS Omnicare to pay $949,000 to settle a False Claims Act (FCA) case.According to news sources, the Pharmacy Benefits Manager (PBM) allegedly prescribed drugs to individuals in long-term residential facilities that were not supported by valid prescriptions and then submitted claims for reimbursement for those prescriptions to Medicare, Medicaid, and TRICARE. Although a jury trial was held last spring, with the judge rejecting post-trial arguments by Omnicare, it is understood that Omnicare plans to appeal.Reporting details of this whistleblower lawsuit during the next edition of Monitor Mondays will be Max Voldman, a partner at Whistleblowers Law, LLP.The weekly broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Adam Brenman, senior healthcare government affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.

The ROAD (Renewing Opportunity in the American Dream) to Housing Act is a bipartisan bill now making its way through Congress. And as today's guest, Alex Armlovich, and his colleagues at the Niskanen Center argue, it is “the first comprehensive bid to tackle the roots of America's‬ affordability crisis in a generation—it correctly‬‭ identifies, and takes initial steps to attack,‬ the interlocking barriers to housing abundance at every level.” Not only that, but the bill is “miraculously‬ bipartisan, and its negotiation and development exhibited a stunning, almost‬ anachronistic return to the old Senate tradition of depolarized collegiality and bipartisan‬ problem-solving.‬”But before discussing the contents of the bill, Alex and Cardiff first talk about recent shifts in housing-policy alliances, the roots of the housing affordability and availability problem, housing experiments that have worked (and haven't), the roll of the “Abundance” movement, and the genuine collective-action problems that housing advocates too often ignore. Then they break down the ROAD to Housing Act into three main buckets, going into detail on each: 1) Regulatory reform, 2) carrots and sticks, and 3) financing and funding. They also comment on what the bill would fix and what it wouldn't, and its chances of becoming law. Finally, Alex and Cardiff reflect on housing, construction, and the nature of physical change in New York City, where both have spent the bulk of their adult lives. Related links: Alex Armlovich about page (at Niskanen Center)Niskanen Center home page (where the upcoming ROAD to Housing Act analysis from Alex and his colleagues will appear) Hosted on Acast. See acast.com/privacy for more information.

SummaryTexas moves closer to primacy for carbon capture and sequestration projects as legal frameworks evolve and landmen navigate an increasingly complex regulatory landscape. Our expert guests break down the latest developments in CCS permitting, pore space ownership, and the practical challenges of putting these massive projects together in today's market.What You'll LearnCurrent status of Texas primacy for CCS well permitting and expected timelineHow pore space ownership varies between Texas and LouisianaWhy large contiguous properties remain essential for CCS project successThe role of unitization and integration in future CCS developmentPipeline challenges that could make or break project economicsLegal considerations around plume migration and potential tort issuesTime Stamps01:00 - Episode & Guest Introductions03:00 - Primacy in Texas06:00 - Primacy in Other States13:00 - Challenges and Considerations in Louisiana17:00 - CCS in West Virginia and Other States21:00 - Ownership & Legal Issues in Texas31:00 - Understanding Carbon Capture Injection Projects33:00 - Challenges in Securing Agreements for Carbon Capture34:00 - Cost and Timeline of Carbon Capture Projects35:00 - Legal Considerations in Carbon Capture39:00 - Unitization and Integration in Carbon Capture47:00 - Pipeline Challenges in Carbon CaptureSnippets from the Episode"The state agency that's been responsible for administering the rules for oil and gas development and has this huge store of knowledge is now going to administer the rules for carbon capture, which is something of an inverse process to oil and gas development."— Jerry Walrath"One of the biggest things that I find day to day that is consuming my time is you have a lack of regulation, and you have a lot of first-of-kind commercial arrangements because you're joining groups together that have not been joined before into what looks kind of like a traditional oil and gas transaction."— KC McAdam"In Louisiana, you're gonna flip that on its head - the surface owner owns the pore space, but there may be oil and gas activity, you're gonna want to make sure that you're covering yourself from the other angle."— KC McAdam"These projects are expensive. They take a very long time to build. You're talking about basically the same sort of cost and timeline to put together a large pipeline or an offshore platform."— KC McAdam"Every mile of pipe you add, you're adding a huge amount in cost just to build the pipe. And then you're also having to look at getting the agreements in place to actually build that pipe."— KC McAdamKey TakeawaysTexas Primacy Progress - MOA Signed, But Timeline UncertainPore Space Ownership Varies Significantly by StateLarge Contiguous Properties Remain Essential for Early ProjectsUnitization Rules Needed for Future CCS DevelopmentPipeline Economics Can Make or Break Project ViabilityLegal Frameworks Still Evolving Around Plume MigrationFirst-of-Kind Commercial Arrangements Create New ChallengesHelp us improve our podcast! Share your thoughts in our quick survey.ResourcesNeed Help With A Project? ⁠⁠⁠⁠Meet With Dudley⁠⁠⁠⁠Need Help with Staffing? Connect with ⁠⁠⁠⁠Dudley Staffing ⁠⁠⁠⁠Streamline Your Title Process with ⁠⁠⁠⁠Dudley Select Title⁠⁠⁠⁠Watch On ⁠⁠⁠⁠Youtube⁠⁠⁠⁠Follow Dudley Land Co. On⁠⁠⁠⁠ LinkedIn⁠⁠⁠⁠Have Questions? ⁠⁠⁠⁠Email us⁠⁠⁠⁠More from Our GuestJerry Walrath - Partner, KMW Energy LawWebsite: kmwenergylaw.comConnect with Jerry Walrath on LinkedInKC McAdam - CCS Legal and Commercial SpecialistSpecializes in hard-to-abate industries and CCS project developmentConnect with KC McAdam on LinkedInMore from Our HostsConnect with ⁠⁠⁠⁠Brent⁠⁠⁠⁠ on LinkedInConnect with ⁠⁠⁠⁠Khalil ⁠⁠⁠⁠on LinkedIn

Curt Moore is the Founder and President of Moat Title Security Co.Mr. Moore graduated in 1991 from the University of Northern Colorado with a Bachelor's Degree in Business Administration – Marketing. Mr. Moore enjoyed a career in the Energy industry spanning thirty years in the fields of Land Management, Regulatory and Governmental Affairs, and retired to spend time on Moat in 2021. Mr. Moore founded Moat on a simple principle of protecting homeowners from home title identity theft using copyrighted legal documents prepared by licensed agents operating in markets on a local level with a focus on customer service and the communities where Moat is present.Learn more: http://moattitlesecurity.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-curt-moore-founder-and-president-of-moat-title-security-co

Curt Moore is the Founder and President of Moat Title Security Co.Mr. Moore graduated in 1991 from the University of Northern Colorado with a Bachelor's Degree in Business Administration – Marketing. Mr. Moore enjoyed a career in the Energy industry spanning thirty years in the fields of Land Management, Regulatory and Governmental Affairs, and retired to spend time on Moat in 2021. Mr. Moore founded Moat on a simple principle of protecting homeowners from home title identity theft using copyrighted legal documents prepared by licensed agents operating in markets on a local level with a focus on customer service and the communities where Moat is present.Learn more: http://moattitlesecurity.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-curt-moore-founder-and-president-of-moat-title-security-co

In this episode of Iron Culture, Helms and Trex have a lengthy discussion about the ECA stack and yohimbine. The history, the mechanisms, the regulatory changes, the practical applications – you name it, they cover it. Don't miss this episode if you have an interest in fat loss, stimulants, or dietary supplementation in general. Also, be sure to check out the newest issue of the MASS Research Review! Learn more at massresearchreview.com Time stamps 0:00 Intro 4:18 New issue of the MASS Research Review 10:42 Helms contest prep update 13:15 The history of the ECA stack and supplement regulation 30:07 Ephedra vs Ephedrine  35:31 Why people took ephedrine / ECA stack 36:30 Trends in PED use over time 45:00 Research on the ECA stack 50:58 Banning lifters for stimulant use 53:15 Effects of ephedrine + caffeine on metabolism and fat loss 1:02:44 What does aspirin really add to the ECA stack? 1:13:00 Do NSAIDs blunt hypertrophy? 1:21:25 How yohimbine works (and yohimbe vs yohimbine distinction) 1:31:10 Regulatory status of yohimbine 1:32:58 Practical applications

In this episode of Medsider Radio, we sat down with Joanna Nathan, CEO and co-founder of Prana Surgical — a startup developing image-guided surgical platforms for precision oncology.  Joanna's career spans translational research at Texas Heart Institute, product development at Saranas, and portfolio management at Mercury Fund and Johnson & Johnson's Center for Device Innovation. She mentors founders through her not-for-profit organization Enventure and teaches entrepreneurship at Rice University's Jones School of Business.In this interview, Joanna shares her framework for evaluating which medtech ideas merit pursuit, revealing three critical signals every founder should look for: clinical urgency that requires no convincing, favorable asymmetry between value and technical risk, and optimal market timing. Joanna also demonstrates how systematic grant applications and strategic resource allocation can extend runway while building investor credibility, and addresses the unique psychological challenges of building life-critical devices.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Joanna Nathan.

In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods, shares insights on key regulatory changes impacting healthcare private equity, current trends in the deal market, and her team’s focus areas for the remainder of the year, including life sciences and FDA-related growth.

Today, we discuss how to navigate all the options out there as you seek your ideal homestead property. We also cover our usual Monday segments. Featured Event August 9: Foraging on the Farm at Strong Roots Resources Strongrootsresources.com Sponsor 1 DiscountMylarBags.com Long-term food storage supplies that won't break the bank. Sponsor 2 AgoristTaxAdvice.com/LFTN Helping entrepreneurs, homesteaders, and freedom-minded folks handle taxes the smart way. Surprise Guest JOHN WILLIS - Buy his cool tactical gear here. Tales from the Prepper Pantry We topped off green bean canning for the year — another seasonal task checked off the list. We're also setting up long-term canned goods storage at Basecamp so it's easier to rotate and access what we've put up. While I was away, Tactical survived thanks to the stash of homemade convenience meals we'd prepped in advance. Proof that a little forethought goes a long way. And this week, we're finally getting seedlings started for the fall garden — about a week later than planned, but they're going in. Frugality Tip If you've got a spare room sitting empty, it might be time to put it to work. We brought in $150 this week just by renting out a bedroom on Airbnb —  just a clean space, a good description, and letting the system do its thing. Sometimes the easiest money is already inside your house. Operation Independence We're gearing up for a trip to Polyface Farm to see Joel Salatin's systems in action. The goal? Learn what we can, adapt what fits, and scale up operations here at the Holler. Always learning, always building. Main Topic of the Day: Finding the Ideal Homestead Everybody wants the perfect homestead. Creek in the back, rich soil, gentle slopes, friendly neighbors, no codes, low taxes, a vast homeschooling network, hospital that is close but not TOO close…Oh — and under $200,000, please. Today, we're digging into how to actually find the IDEAL land for your homestead — starting with the real questions, not the fantasy map. Where to go in the state How to choose land Where the best community is Regulatory environment To rent or to own? What does ideal mean? WHY ARE YOUR DOING THIS? What does your ideal day on your land actually look like? Is this about freedom? Fear? Feeding your family? Are you chasing a dream… or running from a disaster? Zac Bauer of  An American Homestead's thoughts on water List what is important to you: Family Hospitals? Entertainment Supplies Church Crime/Safety Kid stuff Tax regulations Cultural mix   HERE IS THE TRUTH THOUGH : the ideal property? It's either taken or priced much higher than you will expect  - and those super nice properties also have hidden problems. That's the problem we're really solving today — what do you do when your dream and your budget don't match? That is when you have to prioritize = prioritize what you truly need in a piece of land as Zac pointed out.  In Fact the best homesteaders I know didn't start with perfect property. They started with a good enough place and made it work. EXAMPLES John Willis, Rock Quarry The Eversoles (bare land) Kerry Brown (off grid) Ryan & Steve (local partners) Shawn Mills (off grid) They didn't find a unicorn property — they built a life anyway. Don't forget — Self-Reliance Festival tickets are still available, but the price goes up soon. If you've been thinking about joining us in Camden this October, now's the time to grab your pass and make a plan. Details are at SelfRelianceFestival.com. Make it a great week. GUYS! Don't forget about the cookbook, Cook With What You Have by Nicole Sauce and Mama Sauce.  Community Follow me on Nostr: npub1u2vu695j5wfnxsxpwpth2jnzwxx5fat7vc63eth07dez9arnrezsdeafsv Mewe Group: https://mewe.com/join/lftn Telegram Group: https://t.me/LFTNGroup Odysee: https://odysee.com/$/invite/@livingfree:b Resources Membership Sign Up Holler Roast Coffee Harvest Right Affiliate Link

Dave Sobel interviews Raffi Jamgotchian, founder and CEO of Triada Networks, about the current landscape of AI adoption in the financial services sector, particularly among small to medium-sized investment firms. Jamgotchian notes that while some clients are eager to embrace AI, others remain hesitant, mirroring trends seen with cloud technology. For those leaning into AI, Triada Networks is focusing on proof of concepts, helping clients structure their data effectively to leverage AI tools, especially in data analytics and research.Regulatory considerations play a significant role in how firms approach AI implementation. Many of Jamgotchian's clients operate in regulated environments, which affects their choice of data models and the types of large language models (LLMs) they can use. The challenge lies in handling sensitive, non-public information without risking regulatory violations. As firms navigate these complexities, the importance of data preparation becomes evident, with varying levels of readiness among clients impacting their ability to utilize AI effectively.Cybersecurity is a critical aspect of the conversation around AI and data management. Jamgotchian highlights that clients are increasingly proactive in seeking guidance on cybersecurity implications related to their business decisions. This shift is attributed to a combination of heightened regulatory scrutiny and a growing awareness of cybersecurity risks in the market. The conversation has evolved from being initiated by service providers to clients actively engaging in discussions about their cybersecurity needs.Looking ahead, Jamgotchian emphasizes the importance of monitoring regulatory developments, particularly from organizations like FINRA and the FCC, as they relate to AI. He anticipates that AI-related lawsuits will emerge, prompting changes in laws that could impact managed service providers (MSPs). The conversation concludes with a recognition that while the MSP landscape is evolving, the core mission of solving business problems through technology remains unchanged, and those who adapt will thrive in the future. All our Sponsors: https://businessof.tech/sponsors/ Do you want the show on your podcast app or the written versions of the stories? Subscribe to the Business of Tech: https://www.businessof.tech/subscribe/Looking for a link from the stories? The entire script of the show, with links to articles, are posted in each story on https://www.businessof.tech/ Support the show on Patreon: https://patreon.com/mspradio/ Want to be a guest on Business of Tech: Daily 10-Minute IT Services Insights? Send Dave Sobel a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/businessoftech Want our stuff? Cool Merch? Wear “Why Do We Care?” - Visit https://mspradio.myspreadshop.com Follow us on:LinkedIn: https://www.linkedin.com/company/28908079/YouTube: https://youtube.com/mspradio/Facebook: https://www.facebook.com/mspradionews/Instagram: https://www.instagram.com/mspradio/TikTok: https://www.tiktok.com/@businessoftechBluesky: https://bsky.app/profile/businessof.tech

In this episode, Stephan Livera and Jad Mubaslat discuss the emerging trend of Bitcoin treasury companies, exploring the potential risks and rewards associated with investing in these entities. Jad expresses skepticism about the sustainability of these companies, particularly regarding their cash flow and financial engineering strategies. The conversation delves into the implications of convertible notes versus preferred shares, tax considerations, and the historical context of financial bubbles. Ultimately, both acknowledge the importance of self-custodying Bitcoin while considering the role of treasury companies in the evolving financial landscape.Takeaways

This week's Friday Five is dominated by a stunning speech from the new SEC Chair, signaling a dramatic shift in U.S. crypto policy. NLW breaks down the speech's implications, from safe harbors and tokenization to a renewed embrace of crypto within securities law. Also on the docket: Powell's hawkish tone and Trump's renewed feud with the Fed, Ray Dalio's bold portfolio advice, a volatile week for crypto treasury companies, and the game-changing JPMorgan-Coinbase partnership that redefines institutional crypto access. All that plus Bitcoin weathers an 80,000-coin liquidation without blinking. Enjoying this content? SUBSCRIBE to the Podcast: https://pod.link/1438693620 Watch on YouTube: https://www.youtube.com/@TheBreakdownBW Subscribe to the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://blockworks.co/newsletter/thebreakdown⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Join the discussion: https://discord.gg/VrKRrfKCz8 Follow on Twitter: NLW: https://twitter.com/nlw Breakdown: https://twitter.com/BreakdownBW

Jennifer Pattison Tuohy joins Mikah Sargent this week on Tech News Weekly! Jennifer shares her first impressions of Alexa Plus. The growing overlap between consumer wellness gadgets and regulated medical technology. And Google's rolling out a machine-learning age verification model to detect account users who are under or over the age of 18. Jennifer Pattison Tuohy has spent some time with Amazon's new, AI-powered Alexa, Alexa Plus. She shares her excitement and criticisms for the new voice assistant. Victoria Song of The Verge joins Mikah to talk about wearable tech companies using the idea of "wellness" technology to skirt FDA regulation on medical technology. And Mikah talks about Google's rollout of a machine-learning age verification model to verify account users' age in the U.S. Hosts: Mikah Sargent and Jennifer Pattison Tuohy Guest: Victoria Song Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit Sponsors: spaceship.com/twit uscloud.com threatlocker.com for Tech News Weekly